Literature DB >> 18484693

Increased arterial stiffness as the marker of vascular involvement in systemic sclerosis.

Orsolya Timár1, Pál Soltész, Szilvia Szamosi, Henrietta Dér, Sándor Szántó, Zoltán Szekanecz, Gabriella Szücs.   

Abstract

OBJECTIVE: Endothelial dysfunction and vasculopathy of the small and large vessels are crucial pathogenic factors in systemic sclerosis (SSc). Accelerated atherosclerosis and impaired flow-mediated vasodilation have been described in SSc. We evaluated arterial stiffness in patients with SSc compared to healthy controls.
METHODS: Augmentation index (AI) and pulse wave velocity (PWV) of the brachial artery were measured in 40 patients with SSc and 35 age and sex matched healthy controls using an arteriograph system.
RESULTS: AI was significantly higher in SSc patients (9.02) compared to controls (-41.15) (p < 0.0001). PWV was similarly higher in patients with SSc (9.67 m/s) than in controls (8.00 m/s) (p = 0.0017). PWV was significantly higher in patients with localized SSc (10.04 +/- 2.01 m/s) compared to those with diffuse SSc (8.39 +/- 1.87 m/s) (p = 0.034). There was a significant, positive linear correlation between AI and PWV (r = 0.32, p = 0.045). We also observed significant correlations between AI and age (r = 0.31, p = 0.048), PWV and age (r = 0.36, p = 0.021), and PWV and disease duration (r = 0.40, p = 0.011) in SSc patients.
CONCLUSION: Increased AI and PWV of the aorta in comparison to age and sex matched healthy controls indicate increased large-vessel stiffness in patients with SSc. PWV and AI are reproducible indicators of the presence and degree of arterial stiffening. Because arterial stiffness may correlate with disease duration and age in patients with SSc, it may be a useful diagnostic test in the assessment of arterial function. Increased vascular stiffness may be therapeutically targeted by statins and other vasoprotective agents during the management of SSc.

Entities:  

Mesh:

Year:  2008        PMID: 18484693

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  19 in total

1.  Neurosonological and cognitive screening for evaluation of systemic sclerosis patients.

Authors:  B R Sakr; R E Rabea; A M Aboulfotooh; N A Kishk
Journal:  Clin Rheumatol       Date:  2019-02-26       Impact factor: 2.980

2.  Evaluation of arterial stiffness and hemodynamics by oscillometric method in patients with systemic sclerosis.

Authors:  Murat Sunbul; Kursat Tigen; Gulsen Ozen; Erdal Durmus; Tarik Kivrak; Altug Cincin; Alper Kepez; Halil Atas; Haner Direskeneli; Yelda Basaran
Journal:  Wien Klin Wochenschr       Date:  2013-07-12       Impact factor: 1.704

Review 3.  Validated methods for assessment of subclinical atherosclerosis in rheumatology.

Authors:  György Kerekes; Pál Soltész; Michael T Nurmohamed; Miguel A Gonzalez-Gay; Maurizio Turiel; Edit Végh; Yehuda Shoenfeld; Iain McInnes; Zoltán Szekanecz
Journal:  Nat Rev Rheumatol       Date:  2012-02-21       Impact factor: 20.543

4.  Right ventricular dysfunction in systemic sclerosis-associated pulmonary arterial hypertension.

Authors:  Ryan J Tedford; James O Mudd; Reda E Girgis; Stephen C Mathai; Ari L Zaiman; Traci Housten-Harris; Danielle Boyce; Benjamin W Kelemen; Anita C Bacher; Ami A Shah; Laura K Hummers; Fredrick M Wigley; Stuart D Russell; Rajeev Saggar; Rajan Saggar; W Lowell Maughan; Paul M Hassoun; David A Kass
Journal:  Circ Heart Fail       Date:  2013-09-01       Impact factor: 8.790

5.  Endothelial dysfunction is present only in the microvasculature and microcirculation of early diffuse systemic sclerosis patients.

Authors:  R T Domsic; C Dezfulian; Al Shoushtari; D Ivanco; E Kenny; C K Kwoh; T A Medsger; H C Champion
Journal:  Clin Exp Rheumatol       Date:  2014-11-05       Impact factor: 4.473

Review 6.  Cardiovascular disease in systemic sclerosis.

Authors:  Francesca Cannarile; Valentina Valentini; Giulia Mirabelli; Alessia Alunno; Riccardo Terenzi; Filippo Luccioli; Roberto Gerli; Elena Bartoloni
Journal:  Ann Transl Med       Date:  2015-01

Review 7.  The burden and measurement of cardiovascular disease in SSc.

Authors:  Mo Yin Mok; Chak Sing Lau
Journal:  Nat Rev Rheumatol       Date:  2010-06-01       Impact factor: 20.543

8.  Arterial distensibility in chronic inflammatory rheumatic disorders.

Authors:  Mustafa Yildiz
Journal:  Open Cardiovasc Med J       Date:  2010-02-23

9.  Systemic vasculopathy with altered vasoreactivity in a transgenic mouse model of scleroderma.

Authors:  Emma C Derrett-Smith; Audrey Dooley; Korsa Khan; Xu Shi-wen; David Abraham; Christopher P Denton
Journal:  Arthritis Res Ther       Date:  2010-04-15       Impact factor: 5.156

Review 10.  Management of cardiovascular disease risk in chronic inflammatory disorders.

Authors:  Mariana J Kaplan
Journal:  Nat Rev Rheumatol       Date:  2009-04       Impact factor: 20.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.